Called the photovoltaic retina implant microarray (PRIMA), the small system uses a subretinal photovoltaic chip implanted in ...

Michael O'Connell, Chief Analytics Officer at Spotfire, on his journey to technology leadership in energy management ...

Here we present a method for the fabrication of microarrays in which presynthesized oligonucleotides are ejected onto a glass surface by a Bubble Jet printing device. The oligonucleotides are then ...

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q3 CY2025, but sales were flat year on ...

About Vaxxas Vaxxas is a biotechnology company pioneering a needle-free vaccination technology designed to enhance immune response, reduce costs, and improve accessibility. The company recently ...

Older adults experiencing irreversible blindness may now be able to see thanks to a system relying on a wireless retinal implant and high-tech glasses ...

A new trial shows that a wireless subretinal implant, the PRIMA system, restored central vision in patients with geographic ...

Brisbane-based ObvioHealth has signed a three-year agreement with clinical-stage biotechnology company Vaxxas to support late-stage trials.

The GeneTitan® family of instruments and proven GeneChip® Array Plates from Thermo Fisher Scientific are the first to provide a hands-free, automated solution for monitoring gene expression and genome ...

A wireless photovoltaic implant shows promise in restoring central vision for patients with macular degeneration, enhancing visual acuity and independence.

Abstract: Feature selection often aims to select a compact feature subset to build a pattern classifier with reduced complexity, so as to achieve improved classification performance. From the ...